Type 2 diabetes mellitus and the risk of sudden cardiac arrest in the community

  • David S. Siscovick
  • Nona Sotoodehnia
  • Thomas D. Rea
  • Trivellore E. Raghunathan
  • Xavier Jouven
  • Rozenn N. Lemaitre


The reduction of mortality from sudden cardiac arrest (SCA) in the setting of coronary heart disease (CHD) remains a major challenge, especially among patients with type 2 diabetes. Diabetes is associated with an increased risk of SCA, at least in part, from an increased presence and extent of coronary atherosclerosis (macrovascular disease). Diabetes also is associated with microvascular disease and autonomic neuropathy; and, these non-coronary atherosclerotic pathophysiologic processes also have the potential to increase the risk of SCA. In this report, we review the absolute and relative risk of SCA associated with diabetes. We summarize recent evidence that suggests that the increase in risk in patients with diabetes is not specific for SCA, as diabetes also is associated with a similar increase in risk for non-SCA CHD death and non-fatal myocardial infarction. These data are consistent with prior observations that coronary atherosclerosis is a major contributor to the increased SCA risk associated with diabetes. We also present previously published and unpublished data that demonstrates that both clinically-recognized microvascular and autonomic neuropathy also are associated with the risk of SCA among treated patients with diabetes, after taking into account prior clinically-recognized heart disease and other risk factors for SCA. We then discuss how these data might inform research and clinical efforts to prevent SCA. Although the prediction of SCA in this “high” risk population is likely to remain a challenge, as it is in other “high” risk clinical populations, we suggest that current recommendations for the prevention of SCA in the community, related to both lifestyle prescriptions and risk factor reduction, are likely to reduce mortality from SCA among patients with diabetes.


Diabetes mellitus Sudden cardiac death Cardiac arrest Coronary heart disease Autonomic dysfunction Microvascular disease 



The research reported in this article was supported by the Seattle Medic One Foundation, Seattle, Washington, and grant R01 HL 42456 from the National Heart, Lung, and Blood Institute, Bethesda, Maryland.


  1. 1.
    Sotoodehnia N, Zivin A, Bardy GH, Siscovick DS. Reducing mortality from sudden cardiac death in the community: lessons from epidemiology and clinical applications research. Cardiovasc Res. 2001;50(2):197–209.CrossRefPubMedGoogle Scholar
  2. 2.
    Spooner PM. Sudden cardiac death: influence of diabetes. Diabetes Obes Metab. 2008;10(7):523–32.CrossRefPubMedGoogle Scholar
  3. 3.
    El-Atat FA, McFarlane SI, Sowers JR, Bigger JT. Sudden cardiac death in patients with diabetes. Curr Diab Rep. 2004;4(3):187–93.CrossRefPubMedGoogle Scholar
  4. 4.
    Fox CS, Coady S, Sorlie PD, Levy D, Meigs JB, D’Agostino Sr RB, et al. Trends in cardiovascular complications of diabetes. JAMA. 2004;292(20):2495–9.CrossRefPubMedGoogle Scholar
  5. 5.
    Lee CD, Folsom AR, Pankow JS, Brancati FL. Cardiovascular events in diabetic and nondiabetic adults with or without history of myocardial infarction. Circulation. 2004;109(7):855–60.CrossRefPubMedGoogle Scholar
  6. 6.
    Hu FB, Stampfer MJ, Solomon CG, Liu S, Willett WC, Speizer FE, et al. The impact of diabetes mellitus on mortality from all causes and coronary heart disease in women: 20 years of follow-up. Arch Intern Med. 2001;161(14):1717–23.CrossRefPubMedGoogle Scholar
  7. 7.
    Lotufo PA, Gaziano JM, Chae CU, Ajani UA, Moreno-John G, Buring JE, et al. Diabetes and all-cause and coronary heart disease mortality among US male physicians. Arch Intern Med. 2001;161(2):242–7.CrossRefPubMedGoogle Scholar
  8. 8.
    Cho E, Rimm EB, Stampfer MJ, Willett WC, Hu FB. The impact of diabetes mellitus and prior myocardial infarction on mortality from all causes and from coronary heart disease in men. J Am Coll Cardiol. 2002;40(5):954–60.CrossRefPubMedGoogle Scholar
  9. 9.
    Kannel WB, Wilson PW, D’Agostino RB, Cobb J. Sudden coronary death in women. Am Heart J. 1998;136(2):205–12.CrossRefPubMedGoogle Scholar
  10. 10.
    Albert CM, Chae CU, Grodstein F, Rose LM, Rexrode KM, Ruskin JN, et al. Prospective study of sudden cardiac death among women in the United States. Circulation. 2003;107(16):2096–101.CrossRefPubMedGoogle Scholar
  11. 11.
    Curb JD, Rodriguez BL, Burchfiel CM, Abbott RD, Chiu D, Yano K. Sudden death, impaired glucose tolerance, and diabetes in Japanese American men. Circulation. 1995;91(10):2591–5.PubMedGoogle Scholar
  12. 12.
    Balkau B, Jouven X, Ducimetiere P, Eschwege E. Diabetes as a risk factor for sudden death. Lancet. 1999;354(9194):1968–9.CrossRefPubMedGoogle Scholar
  13. 13.
    Jouven X, Lemaitre RN, Rea TD, Sotoodehnia N, Empana JP, Siscovick DS. Diabetes, glucose level, and risk of sudden cardiac death. Eur Heart J. 2005;26(20):2142–7.CrossRefPubMedGoogle Scholar
  14. 14.
    Targher G, Bertolini L, Zenari L, Lippi G, Pichiri I, Zoppini G, et al. Diabetic retinopathy is associated with an increased incidence of cardiovascular events in Type 2 diabetic patients. Diabet Med. 2008;25(1):45–50.PubMedGoogle Scholar
  15. 15.
    Wheeler SG, Ahroni JH, Boyko EJ. Prospective study of autonomic neuropathy as a predictor of mortality in patients with diabetes. Diabetes Res Clin Pract. 2002;58(2):131–8.CrossRefPubMedGoogle Scholar
  16. 16.
    Rathmann W, Ziegler D, Jahnke M, Haastert B, Gries FA. Mortality in diabetic patients with cardiovascular autonomic neuropathy. Diabet Med. 1993;10(9):820–4.CrossRefPubMedGoogle Scholar
  17. 17.
    Ewing D, Campbell I, Clarke B. The natural history of diabetic autonomic neuropathy. Q J Med. 1980;49:95–108.PubMedGoogle Scholar
  18. 18.
    Demirovic J, Myerburg RJ. Epidemiology of sudden coronary death: an overview. Prog Cardiovasc Dis. 1994;37(1):39–48.CrossRefPubMedGoogle Scholar
  19. 19.
    Zheng ZJ, Croft JB, Giles WH, Mensah GA. Sudden cardiac death in the United States, 1989 to 1998. Circulation. 2001;104(18):2158–63.CrossRefPubMedGoogle Scholar
  20. 20.
    Rea TD, Pearce RM, Raghunathan TE, Lemaitre RN, Sotoodehnia N, Jouven X, et al. Incidence of out-of-hospital cardiac arrest. Am J Cardiol. 2004;93(12):1455–60.CrossRefPubMedGoogle Scholar
  21. 21.
    Kucharska-Newton AM, Couper DJ, Pankow JS, Prineas RJ, Rea TD, Sotoodehnia N, et al. Diabetes and the risk of sudden cardiac death, the Atherosclerosis Risk in Communities study. Acta Diabetol 2009.Google Scholar
  22. 22.
    Buxton AE, Calkins H, Callans DJ, DiMarco JP, Fisher JD, Greene HL, et al. ACC/AHA/HRS 2006 key data elements and definitions for electrophysiological studies and procedures: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (ACC/AHA/HRS Writing Committee to Develop Data Standards on Electrophysiology). Circulation. 2006;114(23):2534–70.CrossRefPubMedGoogle Scholar
  23. 23.
    Pankow JS, Kwan DK, Duncan BB, Schmidt MI, Couper DJ, Golden S, et al. Cardiometabolic risk in impaired fasting glucose and impaired glucose tolerance: the Atherosclerosis Risk in Communities Study. Diabetes Care. 2007;30(2):325–31.CrossRefPubMedGoogle Scholar
  24. 24.
    Suarez GA, Clark VM, Norell JE, Kottke TE, Callahan MJ, O’Brien PC, et al. Sudden cardiac death in diabetes mellitus: risk factors in the Rochester diabetic neuropathy study. J Neurol Neurosurg Psychiatry. 2005;76(2):240–5.CrossRefPubMedGoogle Scholar
  25. 25.
    Singh JP, Larson MG, O’Donnell CJ, Wilson PF, Tsuji H, Lloyd-Jones DM, et al. Association of hyperglycemia with reduced heart rate variability (The Framingham Heart Study). Am J Cardiol. 2000;86(3):309–12.CrossRefPubMedGoogle Scholar
  26. 26.
    Schroeder EB, Chambless LE, Liao D, Prineas RJ, Evans GW, Rosamond WD, et al. Diabetes, glucose, insulin, and heart rate variability: the Atherosclerosis Risk in Communities (ARIC) study. Diabetes Care. 2005;28(3):668–74.CrossRefPubMedGoogle Scholar
  27. 27.
    Kahn JK, Sisson JC, Vinik AI. QT interval prolongation and sudden cardiac death in diabetic autonomic neuropathy. J Clin Endocrinol Metab. 1987;64(4):751–4.CrossRefPubMedGoogle Scholar
  28. 28.
    Bellavere F, Ferri M, Guarini L, Bax G, Piccoli A, Cardone C, et al. Prolonged QT period in diabetic autonomic neuropathy: a possible role in sudden cardiac death? Br Heart J. 1988;59(3):379–83.CrossRefPubMedGoogle Scholar
  29. 29.
    Ewing DJ, Boland O, Neilson JM, Cho CG, Clarke BF. Autonomic neuropathy, QT interval lengthening, and unexpected deaths in male diabetic patients. Diabetologia. 1991;34(3):182–5.CrossRefPubMedGoogle Scholar
  30. 30.
    Whitsel EA, Boyko EJ, Rautaharju PM, Raghunathan TE, Lin D, Pearce RM, et al. Electrocardiographic QT interval prolongation and risk of primary cardiac arrest in diabetic patients. Diabetes Care. 2005;28(8):2045–7.CrossRefPubMedGoogle Scholar
  31. 31.
    Siscovick DS, Podrid PJ. Overview of sudden cardiac arrest and sudden cardiac death. In: Olshansky B, Manaker S, editors. UpToDate; 2009.Google Scholar
  32. 32.
    Buse JB, Ginsberg HN, Bakris GL, Clark NG, Costa F, Eckel R, et al. Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association. Circulation. 2007;115(1):114–26.CrossRefPubMedGoogle Scholar
  33. 33.
    Ryden L, Standl E, Bartnik M, Van den Berghe G, Betteridge J, de Boer MJ, et al. Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). Eur Heart J. 2007;28(1):88–136.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  • David S. Siscovick
    • 1
  • Nona Sotoodehnia
    • 2
  • Thomas D. Rea
    • 2
  • Trivellore E. Raghunathan
    • 3
  • Xavier Jouven
    • 4
  • Rozenn N. Lemaitre
    • 2
  1. 1.Medicine and EpidemiologyUniversity of Washington, Cardiovascular Health Research UnitSeattleUSA
  2. 2.MedicineUniversity of Washington, Cardiovascular Health Research UnitSeattleUSA
  3. 3.University of Michigan, Institute for Social ResearchAnn ArborUSA
  4. 4.INSERMParisFrance

Personalised recommendations